Liat Shargian-Alon
14PUBLICATIONS
30CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (14)
Sort by Publication Date:
|May 23, 2024
Gilteritinib with or without venetoclax for relapsed/refractory FLT3-mutated acute myeloid leukaemia.Eitan Kugler, Inbar Cohen, Irina Amitai
|Jul 13, 2023
Extracorporeal photopheresis induces NETosis in neutrophils derived from patients with chronic graft-vs-host disease.Idan Goldberg, Galit Granot, Alona Telerman
|Jan 18, 2023
Infection prevention practices among EBMT hematopoietic cell transplant centers: the EBMT Infectious Disease Working Party survey.Moshe Yeshurun, Uri Rozovski, Liat Shargian
|Oct 25, 2022
CAR-T cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis.Liat Shargian, Pia Raanani, Moshe Yeshurun
|Oct 17, 2022
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study.Liat Shargian, Odelia Amit, Hanna Bernstine
|Jun 29, 2022
Chimeric antigen receptor T-cell therapy is superior to standard of care as second-line therapy for large B-cell lymphoma: A systematic review and meta-analysis.Liat Shargian, Pia Raanani, Moshe Yeshurun
Pageof 3
Frequent Collaborators
4 joint publications
Ofir Wolach
3 joint publications
Shai Shimony
3 joint publications
Oren Pasvolsky
1 joint publications
Tsila Zukerman
1 joint publications
Netanel A Horowitz
1 joint publications
Ron Ram
1 joint publications
Moshe Yeshurun
1 joint publications
Malgorzata Mikulska
1 joint publications
Jan Styczynski
1 joint publications
Diana Averbuch
